BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21534146)

  • 1. Social contexts influence ethical considerations of research.
    Gordon JB; Levine RJ; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):24-30. PubMed ID: 21534146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 3. Social contexts, social media, and human subjects research.
    Foulkes M
    Am J Bioeth; 2011 May; 11(5):35-6. PubMed ID: 21534149
    [No Abstract]   [Full Text] [Related]  

  • 4. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
    Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
    Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research impacting social contexts: the moral import of community-based participatory research.
    Munoz R; Fox MD
    Am J Bioeth; 2011 May; 11(5):37-8. PubMed ID: 21534150
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing therapies less effective than the best current standard: ethical beliefs in an international sample of researchers.
    Kent DM; Mwamburi M; Cash RA; Rabin TL; Bennish ML
    Am J Bioeth; 2003; 3(2):W11. PubMed ID: 14635629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plea for pragmatism in clinical research ethics.
    Brendel DH; Miller FG
    Am J Bioeth; 2008 Apr; 8(4):24-31. PubMed ID: 18576248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of social, cultural, and economic contexts, and empirical research in examining "undue inducement".
    Klitzman R
    Am J Bioeth; 2005; 5(5):19-21. PubMed ID: 16179300
    [No Abstract]   [Full Text] [Related]  

  • 10. The limitations of "vulnerability" as a protection for human research participants.
    Levine C; Faden R; Grady C; Hammerschmidt D; Eckenwiler L; Sugarman J;
    Am J Bioeth; 2004; 4(3):44-9. PubMed ID: 16192138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten questions institutional review boards should ask when reviewing international clinical research protocols.
    Fitzgerald DW; Wasunna A; Pape JW
    IRB; 2003; 25(2):14-8. PubMed ID: 12833903
    [No Abstract]   [Full Text] [Related]  

  • 12. IRBs and the long-term social implications of research.
    de Melo-Martin I
    Am J Bioeth; 2011 May; 11(5):22-3. PubMed ID: 21534145
    [No Abstract]   [Full Text] [Related]  

  • 13. The need for topically focused efforts to deal with the long-term social implications of research.
    Benya F
    Am J Bioeth; 2011 May; 11(5):19-20. PubMed ID: 21534143
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the case for the regulation of research.
    Wilkinson T
    Am J Bioeth; 2010 Aug; 10(8):63-5. PubMed ID: 20694915
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical human-research protections: not universal and not uniform.
    Fleming DA; Reynolds D
    Am J Bioeth; 2008 Nov; 8(11):21-2. PubMed ID: 19061102
    [No Abstract]   [Full Text] [Related]  

  • 16. Undue inducements and reasonable risks: will the dismal science lead to dismal research ethics?
    London AJ
    Am J Bioeth; 2005; 5(5):29-32. PubMed ID: 16179305
    [No Abstract]   [Full Text] [Related]  

  • 17. What to do when the risk environment is rapidly shifting and heterogeneous? Anticipatory governance and real-time assessment of social risks in multiply marginalized populations can prevent IRB mission creep, ethical inflation or underestimation of risks.
    Ozdemir V
    Am J Bioeth; 2009 Nov; 9(11):65-8. PubMed ID: 19882466
    [No Abstract]   [Full Text] [Related]  

  • 18. When "minimal risk" research yields clinically-significant data, maybe the risks aren't so minimal.
    Sharp HM; Orr RD
    Am J Bioeth; 2004; 4(2):W32-6. PubMed ID: 15186687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compensation for research-related injury in NIH-sponsored HIV/AIDS clinical trials in Africa.
    Mamotte N; Wassenaar D; Singh N
    J Empir Res Hum Res Ethics; 2013 Feb; 8(1):45-54. PubMed ID: 23485670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medical research-ethics applied to social sciences: relevance, limits, issues and necessary adjustments].
    Desclaux A
    Bull Soc Pathol Exot; 2008 Apr; 101(2):77-84. PubMed ID: 18543697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.